X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Fact Check Friday: The truth about the cost of 340B to patients

By Nicole Longo  |    January 26, 2018
The 340B program was designed to increase access to medicines for vulnerable or uninsured patients through safety-net facilities, but all signs point to 340B doing the opposite – distorting the...   Read More

Fact Check Friday: The truth about IPAB

By Nicole Longo  |    June 9, 2017
This week on Fact Check Friday, we’re taking a closer look at the Independent Payment Advisory Board (IPAB) – the panel tasked with proposing cuts to Medicare if spending exceeds a certain growth...   Read More

3 things to know about 2016 drug approvals

By Andrew Powaleny  |    January 6, 2017
In 2016, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 22 new medicines to treat a broad range of illnesses for patients in need. These...   Read More

Fact Check Friday: Biopharmaceutical company communications with payers

By Andrew Powaleny  |    April 29, 2016
Today, we’re examining how and what biopharmaceutical companies communicate with payers about a medicine prior to its approval by the U.S. Food and Drug Administration (FDA). MYTH:...   Read More

Fact Check Friday: The truth about Industry’s role in R&D

By Andrew Powaleny  |    October 23, 2015
As a follow-up to this blog we posted last year, PhRMA is excited to share new data that provides a fresh look at the significant investment of America’s biopharmaceutical companies make in R&D....   Read More

Fact Check Friday: Medicaid spending on prescription medicines

By Allyson Funk  |    October 16, 2015
This week on Fact Check Friday, we’re talking about Medicaid. Medicaid provides health coverage for low-income and disabled individuals and is jointly funded by states and the federal government.    Read More

Medicare Monday: Fact Checking

By Allyson Funk  |    August 17, 2015
In case you missed it, Friday we did some Medicare myth busting in our Fact Check Friday series. Check out the post here: The Truth About Negotiation in Medicare Part D   Read More

Fact Check Friday: The Truth About Negotiation in Medicare Part D

By Allyson Funk  |    August 14, 2015
This week on Fact Check Friday, we’re talking about something of an urban legend: that there isn’t any negotiation in Medicare Part D.  MYTH:  There is no negotiation in Medicare Part D.  FACT: ...   Read More

Fact Check Friday: The Truth about Spending on Cancer Medicines

By Holly Campbell  |    August 7, 2015
  This week, as part of our Catalyst blog series: Fact Check Friday, we debunk a myth about cancer care to show that maybe the sky isn’t falling after all. MYTH: Cancer drug costs are...   Read More

Fact Check Friday: The Truth about IPR and Biopharmaceutical Patents

By Tina Stow  |    July 31, 2015
Today, we’re pleased to be kicking off our newest Catalyst blog series: Fact Check Friday. We’ll be using this space to separate truth from fiction and set the record straight when the rhetoric...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates